Nadia Mazarakis

99 Commercial Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Journal: Frontiers in immunology

Published: January 16, 2026

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Journal: Vaccine

Published: January 08, 2026

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Journal: Frontiers in immunology

Published: January 02, 2026

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

Journal: The Journal of infection

Published: November 11, 2025

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial.

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial.

Journal: Vaccines

Published: October 05, 2025

Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial.

Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial.

Journal: Nature communications

Published: May 06, 2025

Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial.

Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial.

Journal: Vaccine

Published: February 18, 2025

Editorial: Sulforaphane and isothiocyanates in health.

Editorial: Sulforaphane and isothiocyanates in health.

Journal: Frontiers in nutrition

Published: January 09, 2025

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

Journal: The Journal of infection

Published: November 07, 2024

Evaluation of SARS-CoV-2 Antibody Response Between Paired Fingerprick (HemaPEN®) and Venepuncture Collected Samples in Children and Adults.

Evaluation of SARS-CoV-2 Antibody Response Between Paired Fingerprick (HemaPEN®) and Venepuncture Collected Samples in Children and Adults.

Journal: Antibodies (Basel, Switzerland)

Published: October 02, 2024

Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection.

Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection.

Journal: Clinical & translational immunology

Published: July 15, 2024

A 38-colour high dimensional immunophenotyping panel for human peripheral blood mononuclear cells.

A 38-colour high dimensional immunophenotyping panel for human peripheral blood mononuclear cells.

Journal: Journal of immunological methods

Published: March 27, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026